Skip to content
DraconiticResearch
Search Sources API
189,280 studies31 sourcesUpdated 51 min ago
PreprintCC BYbioRxiv

Robust ORF Deconvolution from Multiple Ribo-seq Datasets with Group LASSO Penalty

  1. 1University of Regensburg

Abstract

Ribo-seq has provided compelling evidence that there are many translated but unannotated ORFs. Despite a growing body of peptidomic support for cryptic ORFs, the computational discovery of weakly translated, short and mutually overlapping ORFs has remained a major bottleneck. Here we introduce PRICE 2, a method designed to resolve these challenging translation events by adapting concepts from isoform deconvolution. PRICE 2 employs a generative model combined with group LASSO regularized regression to jointly infer active ORFs across multiple sequencing runs. In a comprehensive benchmark, PRICE 2 outperformed thirteen state-of-the-art tools in detecting short and overlapping ORFs. Orthogonal validation via immunopeptidomics demonstrated that ORFs identified by PRICE 2 enable the discovery of [~]40% more cryptic MHC-I peptides than the best-performing competing tool at a fixed false discovery rate. By analyzing public ribo-seq data across 45 distinct cell and tissue types, we constructed ORF-stock, a comprehensive database of non-canonical ORFs for immunopeptidomic studies.

Related

  1. DECONVersation: Single Cell Foundation Model-Derived Embeddings for Robust Cell Type Deconvolution of Bulk RNA-seq
    A. Oku, H. Geiger, N. Robine +1
    bioRxivPreprintCC BY-NC-NDFull textBioinformatics & computational biologybioRxiv
  2. Robust evidence for theta-band rhythmicity in behavior across two dense-sampling datasets
    Mengting Xu, Esperanza Badaya, Mehdi Senoussi +1
    Communications PsychologyPeer-reviewedCC BY 4.0Full text1 citedNeurosciencePMC
  3. Robust Identification of Drug Mechanism of Action Associated Genes Across Heterogeneous Drug Treated Datasets
    M. Sharmin, M. Aziz, E. Mathe
    bioRxivPreprintCC0Full textBioinformatics & computational biologybioRxiv
  4. Deconvolution of the mechanisms of T cell drug response in multiple myeloma induction therapy
    L. T. Graybuck, L. Y. Okada, W.-L. Chang +19
    bioRxivPreprintCC BY-NC-NDFull textImmunologybioRxiv
  5. Data paper: Cross-species datasets on individual associative learning to regulate access to shared resources in group-housed gestating sows and lactating dairy cows
    Charlotte Gaillard, Anna Blanc, Clémentine Deroiné +5
    Animal - Open SpacePeer-reviewedCC BY 4.0Full textGeneral biologyHAL
BibTeX
@misc{maidhof2026robust,
  title = {{Robust ORF Deconvolution from Multiple Ribo-seq Datasets with Group LASSO Penalty}},
  author = {K. Maidhof and A. Schlosser and F. Erhard},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.01.755973},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.01.755973v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Robust ORF Deconvolution from Multiple Ribo-seq Datasets with Group LASSO Penalty
AU  - K. Maidhof
AU  - A. Schlosser
AU  - F. Erhard
PY  - 2026
DA  - 2026/10/01
PB  - bioRxiv
DO  - 10.64898/2026.10.01.755973
UR  - https://www.biorxiv.org/content/10.64898/2026.10.01.755973v1
AB  - Ribo-seq has provided compelling evidence that there are many translated but unannotated ORFs. Despite a growing body of peptidomic support for cryptic ORFs, the computational discovery of weakly translated, short and mutually overlapping ORFs has remained a major bottleneck. Here we introduce PRICE 2, a method designed to resolve these challenging translation events by adapting concepts from isoform deconvolution. PRICE 2 employs a generative model combined with group LASSO regularized regression to jointly infer active ORFs across multiple sequencing runs. In a comprehensive benchmark, PRICE 2 outperformed thirteen state-of-the-art tools in detecting short and overlapping ORFs. Orthogonal validation via immunopeptidomics demonstrated that ORFs identified by PRICE 2 enable the discovery of [~]40% more cryptic MHC-I peptides than the best-performing competing tool at a fixed false discovery rate. By analyzing public ribo-seq data across 45 distinct cell and tissue types, we constructed ORF-stock, a comprehensive database of non-canonical ORFs for immunopeptidomic studies.
ER  -